Timeline Partners with Lancôme
Share this article
Swiss biotech Timeline, born at EPFL Innovation Park, has entered a landmark global partnership with Lancôme, the flagship beauty brand of L’Oréal. The collaboration marks the first worldwide large-scale commercialization of Timeline’s proprietary longevity molecule, Mitopure®, within a global skincare brand.
For Timeline, this partnership represents the culmination of nearly two decades of scientific research and over CHF 50 million invested in R&D. For Lancôme, it signals a bold step forward in its “Longevity Integrative Science” strategy — anchoring beauty innovation in deep biological mechanisms rather than surface-level aesthetics.
From EPFL Labs to Global Beauty
Founded in 2007 by Patrick Aebischer, former EPFL President, and Dr. Chris Rinsch, with early backing from visionary investors including André Hoffmann and Pierre Landolt, Timeline emerged from fundamental neuroscience research before shifting its focus to muscle health, mobility, and ultimately, cellular longevity.
At the heart of its innovation lies Mitopure®, a highly pure form of Urolithin A. Rather than promising a “miracle pill,” Timeline positions its molecule as something more fundamental.
Mitopure® works by activating mitophagy, the natural recycling process of mitochondria — the “power plants” of our cells. As we age, damaged mitochondria accumulate, reducing cellular energy efficiency. By stimulating their renewal, Mitopure® supports healthier cellular function across muscle, immune, and skin systems.
Longevity, Backed by Science
Timeline’s scientific credibility rests on 18 years of research, 25 clinical trials and more than 50 global patents. The company has already partnered with Nestlé Health Science and L’Oréal. With Lancôme, the scale changes dramatically.
The new skincare range, integrating Mitopure®, will be officially unveiled at the American Academy of Dermatology Congress in Denver in March 2026.
As Vania Lacascade, Global Brand President of Lancôme, said:
“We are defining a new scientific era where beauty is proactive, decoding the core biological mechanisms of skin aging.”
From Scientific Vision to Industrial Scale
Following years of clinical validation and product development, Timeline is now entering a new phase: global industrialization and mass-market deployment.
Supported by patient capital and deeply rooted in Swiss scientific rigor, Timeline embodies a distinctive model of longevity innovation — one built on biological understanding, not hype.
As Chris Rinsch, co-founder and President of Timeline, notes:
“This partnership represents a unique opportunity to democratize our longevity molecule, Mitopure, making its advanced benefits more widely accessible than ever.”
➡️ Source: Press Release | 📸 ©Lancôme